Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 41

1.

A comparative analysis of host responses to avian influenza infection in ducks and chickens highlights a role for the interferon-induced transmembrane proteins in viral resistance.

Smith J, Smith N, Yu L, Paton IR, Gutowska MW, Forrest HL, Danner AF, Seiler JP, Digard P, Webster RG, Burt DW.

BMC Genomics. 2015 Aug 4;16:574. doi: 10.1186/s12864-015-1778-8.

2.

Risk assessment of H2N2 influenza viruses from the avian reservoir.

Jones JC, Baranovich T, Marathe BM, Danner AF, Seiler JP, Franks J, Govorkova EA, Krauss S, Webster RG.

J Virol. 2014 Jan;88(2):1175-88. doi: 10.1128/JVI.02526-13. Epub 2013 Nov 13.

3.

Effect of passive immunization on immunogenicity and protective efficacy of vaccination against a Mexican low-pathogenic avian H5N2 influenza virus.

Forrest HL, Garcia A, Danner A, Seiler JP, Friedman K, Webster RG, Jones JC.

Influenza Other Respir Viruses. 2013 Nov;7(6):1194-201. doi: 10.1111/irv.12140. Epub 2013 Jul 25.

4.

Adaptation of pandemic H1N1 influenza viruses in mice.

Ilyushina NA, Khalenkov AM, Seiler JP, Forrest HL, Bovin NV, Marjuki H, Barman S, Webster RG, Webby RJ.

J Virol. 2010 Sep;84(17):8607-16. doi: 10.1128/JVI.00159-10. Epub 2010 Jun 30.

5.

Effect of neuraminidase inhibitor-resistant mutations on pathogenicity of clade 2.2 A/Turkey/15/06 (H5N1) influenza virus in ferrets.

Ilyushina NA, Seiler JP, Rehg JE, Webster RG, Govorkova EA.

PLoS Pathog. 2010 May 27;6(5):e1000933. doi: 10.1371/journal.ppat.1000933.

6.

A comparative analysis of chromosomal aberrations in cultured human lymphocytes due to fluoroquinolone drugs at different expression periods.

Anupama M, Seiler JP, Murthy PB.

Arch Toxicol. 2010 May;84(5):411-20. doi: 10.1007/s00204-009-0509-9. Epub 2010 Jan 5.

PMID:
20049419
7.

Immunization with reverse-genetics-produced H5N1 influenza vaccine protects ferrets against homologous and heterologous challenge.

Govorkova EA, Webby RJ, Humberd J, Seiler JP, Webster RG.

J Infect Dis. 2006 Jul 15;194(2):159-67. Epub 2006 Jun 9.

PMID:
16779721
8.
9.

Quality management of pharmacology and safety pharmacology studies.

Spindler P, Seiler JP.

Fundam Clin Pharmacol. 2002 Apr;16(2):83-90.

PMID:
12031061
10.

Pharmacodynamic activity of drugs and ecotoxicology--can the two be connected?

Seiler JP.

Toxicol Lett. 2002 May 10;131(1-2):105-15. Review.

PMID:
11988363
11.

The toxicology of iodate: a review of the literature.

Bürgi H, Schaffner TH, Seiler JP.

Thyroid. 2001 May;11(5):449-56. Review.

PMID:
11396703
12.

Chirality--from molecules to organisms.

Seiler JP.

Arch Toxicol Suppl. 1995;17:491-8. Review. No abstract available.

PMID:
7786185
13.

Pentachlorophenol.

Seiler JP.

Mutat Res. 1991 Jan;257(1):27-47. Review.

PMID:
1987456
15.

The mutagenic activity of sodium perborate.

Seiler JP.

Mutat Res. 1989 Oct;224(2):219-27.

PMID:
2677709
16.

Chemical impurity as the possible cause of nitrofen mutagenicity.

Seiler JP.

Carcinogenesis. 1985 Dec;6(12):1811-3.

PMID:
3905043
17.

Uptake, metabolism and mutagenic activity of aromatic glycidyl compounds.

Seiler JP.

Chem Biol Interact. 1984 Oct;51(3):347-56.

PMID:
6386198
18.

The mutagenicity of mono- and di-functional aromatic glycidyl compounds.

Seiler JP.

Mutat Res. 1984 Mar;135(3):159-67.

PMID:
6369127
19.
21.

Criteria for the standardization of Salmonella mutagenicity tests: results of a collaborative study. I. Introduction.

Seiler JP.

Teratog Carcinog Mutagen. 1983;3(2):183-5. No abstract available.

PMID:
6133372
22.

The Salmonella/microsome assay: some possible causes for interlaboratory variations.

Friederich U, Aeschbacher HU, Seiler JP, Würgler FE.

Mutat Res. 1982 Feb;103(2):133-20. No abstract available.

PMID:
7035919
23.

Second European workshop on bacterial in vitro mutagenicity test systems (Ames test meeting 1979).

Seiler JP, Mattern IE, Green MH, Anderson D.

Mutat Res. 1980 Feb;74(1):71-5. No abstract available.

PMID:
6987504
24.

Meeting report: second European workshop on bacterial in vitro mutagenicity test systems.

Seiler JP, Mattern IE, Green MH, Anderson D.

Environ Mutagen. 1980;2(1):97-100. No abstract available.

PMID:
7035161
26.

Phenoxyacids as inhibitors of testicular DNA synthesis in male mice.

Seiler JP.

Bull Environ Contam Toxicol. 1979 Jan;21(1-2):89-92. No abstract available.

PMID:
444715
27.
28.

The mutagenic mode of action of benzimidazole.

Seiler JP.

Experientia. 1978 Jul 15;34(7):851-3. No abstract available.

PMID:
352717
29.

The genetic toxicology of phenoxy acids other than 2,4,5-T.

Seiler JP.

Mutat Res. 1978;55(3-4):197-226. Review. No abstract available.

PMID:
107443
31.
34.
35.

Proceedings: On the mutagenic mode of action of benzimidazoles.

Seiler JP.

Mutat Res. 1975 Aug;29(2):238-9. No abstract available.

PMID:
1186743
36.

In vivo mutagenic interaction of nitrite and ethylenethiourea.

Seiler JP.

Experientia. 1975 Feb 15;31(2):214-5. No abstract available.

PMID:
1089551
37.

Toxicology and genetic effects of benzimidazole compounds.

Seiler JP.

Mutat Res. 1975;32(2):151-68. Review. No abstract available.

PMID:
765792
38.

Ethylenethiourea (ETU), a carcinogenic and mutagenic metabolite of ethylene bis-dithiocarbamate.

Seiler JP.

Mutat Res. 1974 Jun;26(3):189-91. No abstract available.

PMID:
4604443
39.

A survey on the mutagenicity of various pesticides.

Seiler JP.

Experientia. 1973 May 15;29(5):622-3. No abstract available.

PMID:
4730312

Supplemental Content

Loading ...
Support Center